Assets 更改
AbbVie USD 148.87B 12.65B 2024-03
Acadia Pharmaceuticals USD 855.1M 106.15M 2024-03
ALKERMES USD 2.12B 12.33M 2024-03
Amgen USD 92.98B 4.17B 2024-03
Biogen USD 26.57B 277.2M 2024-03
BioMarin Pharmaceutical USD 6.87B 31.07M 2024-03
Bristol-Myers Squibb USD 99.03B 7.77B 2024-03
Eli Lilly USD 63.94B 6.03B 2024-03
Gilead Sciences USD 56.29B 5.83B 2024-03
Intra Cellular Therapies USD 747.04M 18.74M 2024-03
Ionis Pharmaceuticals USD 2.76B 226.14M 2024-03
J&J USD 171.97B 5.9B 2024-03
Malin Corporation EUR 116.6M 14.8M 2023-12
Merck USD 105.85B 878M 2024-03
Neurocrine Biosciences USD 3.47B 624.2M 2024-03
Otsuka Holdings JPY 3.45T 88.54B 2024-03
Pfizer USD 221.1B 6.07B 2024-03
Regeneron Pharmaceuticals USD 34.37B 1.29B 2024-03
Vertex Pharmaceuticals USD 23.92B 2.19B 2024-03



ALKERMES 资产 - 当前值,历史数据,预测,统计,图表和经济日历 - Jun 2024.